ConductScience.org, home

Paper33564310

ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19.

Niu X and 3 others. J Oncol, 2021. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19. Papers, record 33564310. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33564310

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19.
PubMed
Journal
J Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2022-04-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Niu XXinhao
2Zhu ZZhe
3Shao EEnming
4Bao JJuanhttps://orcid.org/0000-0001-9806-9628

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125613900Proteomics. Tissue-based map of the human proteome.Science2015https://conductscience.org/library/papers/25613900PubMed
228407145GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.Nucleic Acids Res2017https://conductscience.org/library/papers/28407145PubMed
316115910Gene signatures of progression and metastasis in renal cell cancer.Clin Cancer Res2005https://conductscience.org/library/papers/16115910PubMed
433256719The emerging COVID-19 research: dynamic and regularly updated science maps and analyses.BMC Med Inform Decis Mak2020https://conductscience.org/library/papers/33256719PubMed
530917908Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism.Life Sci2019https://conductscience.org/library/papers/30917908PubMed
628732212UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.Neoplasia2017https://conductscience.org/library/papers/28732212PubMed
731856918The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC).J Immunother Cancer2019https://conductscience.org/library/papers/31856918PubMed
832404514COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions.mSphere2020https://conductscience.org/library/papers/32404514PubMed
915068665ONCOMINE: a cancer microarray database and integrated data-mining platform.Neoplasia2004https://conductscience.org/library/papers/15068665PubMed
1025516649Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.World J Gastroenterol2014https://conductscience.org/library/papers/25516649PubMed
1116299227Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.Clin Cancer Res2005https://conductscience.org/library/papers/16299227PubMed
1232038957Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value.Transl Androl Urol2019https://conductscience.org/library/papers/32038957PubMed
1327156098Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.DNA Repair (Amst)2016https://conductscience.org/library/papers/27156098PubMed
1415842733SYK expression in human breast cancer.J Carcinog2005https://conductscience.org/library/papers/15842733PubMed
1515870086
Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Ann Oncol2005https://conductscience.org/library/papers/15870086PubMed
1629092952TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.Cancer Res2017https://conductscience.org/library/papers/29092952PubMed
1732640276Mining therapeutic and prognostic significance of STATs in renal cell carcinoma with bioinformatics analysis.Genomics2020https://conductscience.org/library/papers/32640276PubMed
1832570038JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.Int Immunopharmacol2020https://conductscience.org/library/papers/32570038PubMed
1931926244Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.Life Sci2020https://conductscience.org/library/papers/31926244PubMed
2030861269Immune infiltration in renal cell carcinoma.Cancer Sci2019https://conductscience.org/library/papers/30861269PubMed

See all 49 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
40576111Angiotensin‑converting enzyme 2 expression in human tumors: Implications for prognosis and therapy (Review).Oncol Rep2025https://conductscience.org/library/papers/40576111PubMed
38255667New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer.Life (Basel)2023https://conductscience.org/library/papers/38255667PubMed
37869088Unraveling the relationship between the renin-angiotensin system and endometrial cancer: a comprehensive review.Front Oncol2023https://conductscience.org/library/papers/37869088PubMed
37568724Significance of Furin Expression in Thyroid Neoplastic Transformation.Cancers (Basel)2023https://conductscience.org/library/papers/37568724PubMed
36419829TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.Front Genet2022https://conductscience.org/library/papers/36419829PubMed
36335375Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy.J Transl Med2022https://conductscience.org/library/papers/36335375PubMed
36293371Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction.Int J Mol Sci2022https://conductscience.org/library/papers/36293371PubMed
34692518A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.Front Oncol2021https://conductscience.org/library/papers/34692518PubMed
34531911TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment.J Oncol2021https://conductscience.org/library/papers/34531911PubMed
34399734Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19.Cancer Cell Int2021https://conductscience.org/library/papers/34399734PubMed
34258261CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.Biomed Res Int2021https://conductscience.org/library/papers/34258261PubMed

Download CSV of cited by

Genes61

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD1C911PubTator's text mininghttps://conductscience.org/library/genes/911NCBI Gene
CD2914PubTator's text mininghttps://conductscience.org/library/genes/914NCBI Gene
CD3D915PubTator's text mininghttps://conductscience.org/library/genes/915NCBI Gene
CD3E916PubTator's text mininghttps://conductscience.org/library/genes/916NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD8B926PubTator's text mininghttps://conductscience.org/library/genes/926NCBI Gene
CSF1R1436PubTator's text mininghttps://conductscience.org/library/genes/1436NCBI Gene
ENTPD1953PubTator's text mininghttps://conductscience.org/library/genes/953NCBI Gene
ETV42118PubTator's text mininghttps://conductscience.org/library/genes/2118NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
GATA32625PubTator's text mininghttps://conductscience.org/library/genes/2625NCBI Gene

See all 61 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33564310

GET https://conductscience.org/api/papers/v1/33564310/references?page=2